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Abstract  
Background: 
Cannabis smoking and cigarette smoking often co-occur, yet limited research has investigated the 
potentially different role impulsivity may play when these behaviours occur in isolation, compared to in 
combination.  
Aims: 
This study examined trait and behavioural impulsivity as a function of both cigarette and cannabis 
smoking.    
Methods: 
Trait impulsivity (BIS-11) was compared between 44 non-smokers, 76 cigarette only, 47 cannabis only 
and 58 cannabis plus cigarette smokers. The effects of cigarette and cannabis smoking on behavioural 
impulsivity (stop-signal and information sampling tasks) were then assessed in 87 of these participants 
during a laboratory session.  
Results: 
Trait impulsivity was significantly higher in cigarette smokers than non-smokers, irrespective of cannabis 
use, except for motor impulsivity, where cigarette smoking was only associated with elevated trait 
impulsivity in non-smokers of cannabis. Dimensions of trait impulsivity were significantly positively 
related to cigarette smoking frequency and nicotine dependence, but not to cannabis smoking frequency 
or dependence. Smoking cigarettes or cannabis was associated with significantly impaired reflection 
impulsivity relative to not smoking either substance. However, no additional increases in reflection 
impulsivity were observed in those who smoked both cigarettes and cannabis. No group differences in 
response inhibition were detected. 
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Conclusions: 
Heightened trait impulsivity appears to be uniquely related to cigarette smoking, whilst the smoking of 
cigarettes or cannabis is associated with impairments in reflection impulsivity. Improved outcomes for 
treating cannabis dependence may result from encouraging concomitant cigarette smokers to cease using 
both drugs simultaneously in order to reduce heightened impulsivity and risk of relapse.  
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Introduction  
Cannabis is the most widely used illicit substance globally (World Drug Report, 2018). In England, primary 
cannabis use accounts for the largest proportion of young people in treatment for substance misuse (Niblett, 
2018). A major factor contributing to cannabis dependence may be co-dependence on nicotine, since many 
cannabis smokers also smoke cigarettes (Hindocha et al., 2016; Rabin and George, 2015), and are more 
likely to relapse to cannabis whilst continuing to smoke cigarettes (Haney et al., 2013). Furthermore, co-
morbid cannabis-cigarette smoking is associated with heavier cigarette smoking relative to cigarette 
smoking only (Agrawal et al., 2011), while cigarette smoking mediates the relationship between cannabis 
use and cannabis dependence (Hindocha et al., 2015). Failure to consider the role of cigarette smoking 
when attempting to understand factors underlying problematic cannabis use may have hindered research 
progress. To date limited research has attempted to disentangle the effects of cannabis smoking from 
cigarette smoking; in particular, the role impulsivity has in supporting dependence on these substances. 
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Distinguishing between cannabis only smokers and those who smoke both cannabis and cigarettes may be 
a critical step towards this goal. 
 
Impulsivity is a multifaceted construct encapsulating a range of trait and behavioural characteristics, where 
delayed rewards are discounted in favour of immediate gratification, actions are prematurely conceived 
without adequate forethought, and decision-making often lacks reflection despite resulting in negative 
consequences (Robbins et al., 2012). Moreover, impulsivity is thought to be involved in the transition to 
addiction for several drugs including cannabis (for reviews see de Wit, 2009; Wrege et al., 2014). Whilst 
heightened impulsiveness may predispose individuals to initiating substance use (e.g. Vergés et al., 2019), 
prolonged drug use may further reduce impulse control through drug-induced neuroadaptations, whereby 
dopaminergic prefrontal cortical processing becomes increasingly subverted by greater subcortical 
automatic conditioned responding, resulting in persistent drug-taking and making drug-related stimuli 
highly salient to users (Berridge and Robinson, 2016; Everitt et al., 2008; Goldstein and Volkow, 2002; 
Piazza and Deroche-Gamonet, 2013).  
 
Trait impulsivity on the Barratt Impulsiveness Scale (BIS) is elevated in several dependent drug user groups 
relative to controls (e.g. Bozkurt et al., 2013; Ersche et al., 2008). Research has been less consistent in 
relation to whether trait impulsivity is elevated in cannabis smokers compared to non-smokers (NS). Some 
studies support this view (Dervaux et al., 2010; Moreno et al., 2012), while others indicate no trait 
differences between dependent (Johnson et al., 2010) or non-dependent cannabis smokers and NS (Clark 
et al., 2009; Field et al., 2006). A possible factor accounting for these discrepant findings is that studies 
have not always controlled for tobacco cigarette smoking in cannabis smokers sampled. In consideration 
of cigarette smoking, Beaton et al. (2014) found cigarette only smokers and cannabis smokers who smoke 
cigarettes both display elevated trait impulsivity on the BIS relative to NS and cannabis only smokers - who 
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did not differ from each other - suggesting cigarette, rather than cannabis smoking was associated with 
heightened impulsivity. In contrast, Gilman et al. (2015) found elevated trait motor and non-planning 
impulsivity in cannabis only smokers relative to NS. In terms of potential additive effects of cannabis and 
cigarette smoking on impulsivity, none were suggested in the work of Beaton et al. (2014), but these could 
not be assessed by Gilman et al. (2015) as no cigarette smokers were included in this study. Furthermore, 
in both studies behavioural impulsivity was not measured.  
 
Behavioural impulsivity is principally conceptualised as manifesting in two forms: response inhibition - the 
ability to inhibit a pre-potent response - and impulsive choice - a preference for smaller immediate over 
larger delayed reward – which have been the most widely studied aspects of impulsive behaviour to date 
(Weafer and de Wit, 2013). While evidence indicates that response inhibition measured by the stop-signal 
task (SST) is impaired following acute cannabis administration (Ramaekers et al., 2006), it is unknown 
whether impulsive behaviour is elevated in cannabis smokers residually following long-term use. When not 
acutely intoxicated, existing evidence suggests that cannabis smokers do not differ from NS on response 
inhibition on the SST (Filbey and Yezhuvath, 2013; Grant et al., 2012), however neither of these studies 
controlled for cigarette smoking in interpretation of task findings. Evidence also indicates that those who 
smoke both cannabis and cigarettes do not differ from NS on impulsive choice measured using a delay 
discounting task (Johnson et al., 2010). Interestingly, in this study cigarettes smoked per day but not bouts 
of cannabis smoked per day predicted greater discounting of reward suggesting impulsive behaviour more 
closely relates to cigarette smoking. However, no study has extended beyond this when comparing the role 
of cigarette smoking and cannabis use in impulsive behaviour. This may be problematic given: 1) existing 
findings implicating chronic nicotine exposure in alteration of response inhibition (e.g. Luijten et al., 2011) 
and impulsive choice (e.g. Kolokotroni et al., 2014), and 2) increasing agreement that stimulant dependence 
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may lead to more severe neurological impairment than cannabis dependence (Bonomo et al., 2019; Van 
Holst and Schilt, 2011). 
 
A dimension of impulsive behaviour now recognised to be distinguishable from response inhibition is 
reflection impulsivity - the tendency to gather and evaluate information prior to decision-making (Kagan, 
1966) – measured using the information sampling task (IST). On the IST respondents make correct or 
incorrect judgments under varying levels of uncertainty, with lower probability of being correct (p(correct)) 
at point of decision-making being indicative of disrupted reflection impulsivity (Clark et al., 2006, 2009). 
Using this paradigm, Clark et al. (2009) found those who smoke both cannabis and cigarettes display 
impaired reflection impulsivity, evidenced through sampling less information and lower p(correct), 
compared to non-users of either drug. Impaired reflection impulsivity on the IST has also been 
demonstrated in adolescent cannabis only smokers relative to controls (Solowij et al., 2012). At no point, 
however, have cigarette only smokers been compared on the IST relative to NS, cannabis only smokers and 
smokers of both cannabis and cigarettes. This is an important next step needed in order to understand the 
effects of cigarette smoking and cannabis smoking on this form of impulsivity. 
 
In summary, given the high prevalence rates of co-morbid cannabis-cigarette smoking, it is critical to 
further understand the role of impulsivity when these behaviours are performed both in isolation and in 
combination. Past research that has attempted to establish the role of impulsivity in cannabis use has been 
limited by a failure to consistently control for co-morbid cigarette smoking. The present study builds on 
previous research by utilising a multivariate approach to understanding the role of impulsivity in cannabis 
use. Differences between cigarette and cannabis smokers on both trait and behavioural impulsivity were 
assessed using a sample that included non-smokers, cigarette only, cannabis only and cannabis plus 
cigarette smokers. Importantly, both cannabis groups in this study used tobacco in their joints ensuring high 
6 
 
ecological validity, accurately representing how cannabis is smoked in Europe. Critically, this design 
enabled the first step towards disentangling cannabis smoking from cigarette smoking with respect to the 
unique relationships different facets of impulsivity may have with each of these behaviours. 
 
Methods  
Participants 
Trait impulsivity participant sample. Trait impulsivity questionnaire data was gathered from a series of 
studies investigating the role of impulsivity in drug use with a total sample of 224. There were 44 non-
smokers (NS; age M = 24.73, SD = 4.57; Male = 57%), 76 cigarette only smokers (age M = 23.55, SD = 
5.75; Male = 55%), 47 cannabis only smokers (age M = 21.98, SD = 4.59; Male = 64%) and 58 cannabis 
plus cigarette smokers (age M = 22.62, SD = 3.37; Male = 74%). Individuals were recruited throughout the 
UK using opportunity and snowball sampling; all participants provided written informed consent. This 
study was approved by the Research Ethics Committees of Leeds Beckett University and the University of 
Leeds (approval reference: 15-0095) and was conducted according to the World Medical Association 
Declaration of Helsinki. Participants were excluded from participating if they: were non-native English 
speakers; reported a history of psychiatric illness as defined in the Diagnostic and Statistical Manual of 
Mental Disorders – 5 (American Psychiatric Association, 2013), including disorders where impulsivity is 
a hallmark feature, e.g. attention deficit hyperactivity disorder; had a brain injury, or severe head trauma; 
were trying to abstain from smoking tobacco or cannabis; or were dependent on any drugs (including 
alcohol) other than nicotine or cannabis.  
 
Participants were assigned to groups according to drug use frequency and duration of use, an approach that 
is common in the smoking literature (e.g. De Leon et al., 2003). In order to reach criteria for a cannabis 
smoker, individuals needed to smoke cannabis once or more a week for the last six months and score ≥ 13 
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on the Cannabis Use Disorders Identification Test - Revised (CUDIT-R), indicative of cannabis dependence 
(Adamson et al., 2010). Cannabis smokers who also smoked cigarettes daily and had done so for the last 
six months were classed as cannabis plus cigarette smokers; those who reported being non-smokers of 
cigarettes were classed as cannabis only smokers. Cigarette smokers must have smoked tobacco cigarettes 
daily for the last six months and were selected in order to match cannabis plus cigarette smokers on 
frequency of cigarette smoking (this ranged between 3 – 20 cigarettes per day). NS reported no use of 
tobacco or any illicit substances and no current/past dependence on any substance.   
 
Behavioural impulsivity participant sample. Eighty-seven participants from the total sample (N = 224) 
also completed behavioural impulsivity tasks. This sample comprised of 30 non-smokers (age M = 24.43, 
SD = 4.15; Male = 47%), 29 cigarette only smokers (age M = 24.97, SD = 7.21; Male = 52%), 13 cannabis 
only smokers (age M = 22.23, SD = 2.83; Male = 46%), and 15 cannabis plus cigarette smokers (age M = 
24.00, SD = 4.36; Male = 80%).  
 
Measures 
Smoking behaviour and craving. Nicotine dependence was assessed using the Fagerström Test for 
Nicotine Dependence (FTND; Heatherton et al., 1991). Cannabis dependence was assessed using the 
CUDIT-R (Adamson et al., 2010). To assess smoking satiety on arrival at the behavioural session 
participants also self-reported recent drug use, drug craving and undertook expired carbon monoxide (CO) 
assessment with a Micro+ Smokerlyzer (Bedfont). Cigarette craving was measured using the Questionnaire 
of Smoking Urges – Brief (QSU; Cox et al., 2001), which consists of two sub-factors: positive (Cronbach’s 
α = .95) and negative craving (α = .94). Cronbach’s α for the QSU total score was .96. Cannabis craving 
was measured using the Marijuana Craving Questionnaire – Short Form (MCQ; Heishman et al., 2009), 
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which consists of four sub-factors: compulsivity, emotionality, expectancy and purposefulness craving.  
Cronbach’s α for sub-factors ranged from .49 - .77 and the MCQ total score α was .77.  
 
Trait impulsivity. Trait impulsivity was assessed using the Barratt Impulsiveness Scale Version 11 (BIS-
11; Patton and Stanford, 1995), which consists of three sub-factors: attentional, motor, and non-planning 
impulsiveness. Cronbach’s α for BIS-11 sub-factors ranged from .70 - .75 and α for the BIS-11 total score 
was .84.   
 
Behavioural impulsivity   
Information sampling task (IST). The IST (Clark et al., 2006) was used to assess reflection impulsivity. 
The IST was composed of a single practice trial followed by 10 trials in each of two conditions: a fixed win 
(FW) condition and a decreasing win (DW) condition. On each trial a 5 × 5 matrix of grey boxes was 
presented, with a panel containing two boxes (one red and one blue) directly below. Selecting a grey box 
caused it to open immediately (for the duration of the trial) revealing a red or blue box. Respondents chose 
how many grey boxes to open, before deciding which of the two colours underlaid the majority in the 
matrix. Upon indicating a decision, any unopened boxes opened and a feedback message “Correct! You 
have won (x) points” or “Wrong! You have lost 100 points” was presented for two seconds. In the FW 
condition, the subject won 100 points for making a correct decision, regardless of the number of boxes 
opened. In the DW condition, the amount available to win started at 250 points decreasing by 10 points 
with each box opened. An incorrect decision resulted in a 100-point deduction from the total points scored. 
A variable delay (1 second minimum) between trial onsets was used ensuring a minimum intertrial interval 
of 30 seconds. Mean probability of being correct at the point of decision (p(correct) is the primary index of 
reflection impulsivity; lower p(correct) is indicative of greater impulsivity. P(correct) is calculated as 
follows (equation 1; Clark et al., 2006): 
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P(Correct) = 
∑ (𝑧𝑘)
𝑧
𝑘=𝐴
2𝑧
  (1) 
Where Z = 25 – (number of boxes opened), and A = 13 – (number of boxes opened of the chosen colour). 
For example, if a decision is made towards red after opening 10 boxes (8 red, 2 blue), then Z = 25 – 10 = 
15, A = 13 – 8 = 5, and P(correct) = [15!/(5! × 10!) + 15!/(6! × 9!) + ... + 15!/(15! × 0!)]/215 = 0.94 (example 
taken from Clark et al., 2006: pg. 518).  
 
Secondary dependent variables include mean number of boxes opened, mean incorrect judgments, mean 
latency of box opening, and total points won.  
 
Stop-signal task (SST). The SST ran through STOP-IT software and was used to evaluate response 
inhibition (Logan et al., 1997; Verbruggen et al., 2008). The present SST ran three blocks of trials (63 trials 
per block; 189 total), preceded by a practice block (15 trials). Trials began with a central fixation point 
presented for 500 ms, immediately followed by either a square or a circle for 1250 ms. Participants had to 
respond (on 75% of trials) by pressing left or right on the keyboard on presentation of a square or circle 
respectively. Randomly (on 25% of trials), participants were presented with an auditory stop-signal that 
occurred after varying delays following presentation of a square/circle. On receipt of this signal, participants 
had to withhold responding for that trial. Stop-signals were presented for 250 ms through external speakers 
and were randomly preceded by an equal number of squares and circles per block. The stop-signal delay 
(SSD) was initially fixed at 250 ms and subsequently titrated by 50 ms contingent on the previous stop-
signal response using a staircase-tracking algorithm. This procedure adjusts the SSD until successful 
inhibition is achieved on 50% of stop-signal trials, allowing for estimation of the stop-signal reaction time 
(SSRT). SSRT was calculated by subtracting SSD from mean primary task reaction time. SSRT is the 
primary dependent variable; longer SSRT is indicative of poor response inhibition. Secondary dependent 
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variables include: SSD, probability of responding on stop-signal trials, percentage of correct and missed 
responses, commission error reaction time and correct response reaction time.  
 
Procedure  
All participants initially completed a questionnaire pack including measures of drug use, drug dependence, 
and trait impulsivity. The behavioural impulsivity sample then attended a test session where behavioural 
impulsivity tasks were completed. Individuals were asked to refrain from consuming > two units of alcohol 
in the 24 hours before the session or any caffeine in the two hours before the session, to avoid residual and 
acute effects of these substances on performance. Cannabis groups were permitted to smoke cannabis ad-
libitum but were asked to avoid using cannabis three hours before the session to avoid acute intoxication 
(Meyer and Quenzer, 2013). Cigarette smoking before the session was ad-libitum. Smoking satiety was 
verified through self-report of last drug use, drug craving and expired CO at arrival to the session.   
 
Statistical analysis  
Data were analysed using SPSS Version 24. Prior to inferential analyses normality was assessed using the 
Shapiro-Wilk test and homogeneity of variance was assessed using Levene’s test. Between-subject t-tests 
were used to compare groups on smoking behaviour and craving scores, and to verify whether participants 
who completed the behavioural impulsivity measures differed significantly from those who completed only 
the trait impulsivity measures in age, smoking behaviour and trait impulsivity scores. Variables violating 
normality were assessed using non-parametric Mann-Whitney U tests. Pearson’s chi-square tests were used 
to compare sex ratio across groups and samples.  
 
Two (cigarette smoking status: cigarette smokers vs non-cigarette smokers) x two (cannabis smoking status: 
(cannabis smokers vs non-cannabis smokers) between-subject ANOVAs were used to compare groups on 
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age, expired CO, trait and behavioural impulsivity scores. Simple effects analyses with Bonferroni 
adjustment for multiple comparisons were used to explore significant interaction effects. On the SST, SSRT 
can only be reliably estimated when the mean probability of responding on stop-signal trials is close to 50% 
(Verbruggen et al., 2019). Consistent with this recommendation and previous work (Congdon et al., 2012), 
all individuals who inhibited less than 40% or greater than 60% of stop-signal trials (reflecting values falling 
one standard deviation outside of the mean probability of responding on stop-signal trials), were therefore 
omitted from analysis. Ten participants (six non-smokers, two cigarette only, one cannabis only, one 
cannabis plus cigarette smokers) were excluded from SST analysis. Pearson’s correlations were used to 
explore relationships between trait impulsivity, drug use and drug dependence, independently by drug 
group. Alpha (two-tailed) was set at p < .05.  
 
Results   
Trait impulsivity participant sample characteristics 
As shown in Table 1, there was no significant main effect of cigarette smoking status or interaction with 
cannabis status on age. However, a significant main effect of cannabis smoking status revealed non-
cannabis smokers were significantly older than cannabis smokers. Sex ratio did not differ significantly 
across groups.  
 
Importantly the two cannabis groups reported comparable levels of cannabis smoking frequency and years 
smoking cannabis. Despite comparable cannabis use, the cannabis plus cigarette group reported 
significantly greater cannabis dependence than the cannabis only smokers. Cannabis plus cigarette smokers 
also reported using tobacco in joints significantly more than cannabis only smokers. Cigarette only smokers 
did not differ significantly from the cannabis plus cigarette group on daily cigarette smoking, years smoking 
tobacco, and levels of nicotine dependence.  
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Trait impulsivity 
There were significant main effects for cigarette smoking status on BIS-11 total scores, (F(1, 220) = 32.76, p 
< .001, ηp2 = .13), along with the attention, (F(1, 220) = 15.63, p < .001, ηp2 = .07), and non-planning subscales, 
(F(1, 220) = 27.95, p < .001, ηp2 = .11), such that individuals who smoked cigarettes scored significantly 
higher than those who did not smoke cigarettes (Figure 1a-c). No significant effects of cannabis smoking 
or interactions were found, (all F(1, 220) < 2.27, p ≥ .101, ηp2 ≤ .01).  
 
For the BIS-11 motor impulsivity subscale, there was again no significant main effect of cannabis, (F < 1, 
p = .773, ηp2 < .001), but a significant main effect of cigarette smoking, (F(1, 220) = 19.14, p < .001, ηp2 = 
.08), this time qualified by a significant cigarette smoking x cannabis smoking interaction, (F(1, 220) = 5.92, 
p = .016, ηp2 = .03; see Figure 1d). Cigarette smoking was again associated with higher levels of impulsivity, 
but simple effects analyses showed that this effect was seen in non-smokers (p < .001), but not smokers (p 
= .178), of cannabis. Motor impulsivity did not differ as a function of cannabis smoking in either cigarette 
smokers (p = .095) or non-cigarette smokers (p = .078).  
 
Associations between trait impulsivity, cigarette use, and nicotine dependence  
As shown in Table 2, in cigarette only smokers, higher total, motor and non-planning impulsivity was 
associated with increased daily smoking of cigarettes and greater levels of nicotine dependence. A negative 
association was revealed between total impulsivity and years smoking tobacco. In contrast, in those who 
smoked cannabis and cigarettes, greater total impulsivity was associated with increased daily cigarette 
smoking, while greater attentional impulsivity was associated with increased levels of nicotine dependence.  
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Associations between trait impulsivity, cannabis use, and cannabis dependence  
No significant relationships were found between trait impulsivity and either cannabis dependence or 
frequency of cannabis use in either cannabis group, with the exception of greater motor impulsiveness 
which was associated with fewer days per week smoking cannabis in the cannabis plus cigarette smoking 
group (see Table 3).    
 
Behavioural impulsivity participant sample characteristics   
There was no significant main effect of cigarette smoking, cannabis smoking or their interaction on age, 
and sex ratio was equal across groups; see Table 4.  
 
Cannabis groups did not differ significantly on weekly and monthly cannabis use, years smoking cannabis, 
cannabis dependence, use of tobacco in joints, or time (hours) since last cannabis use prior to the session 
(Table 4). The two cannabis groups also reported comparable cannabis craving on (total and subscales of) 
the MCQ on arrival at the session. 
 
Cigarette only and cannabis plus cigarette groups did not differ significantly on cigarettes smoked per day, 
years smoking tobacco, nicotine dependence, or time (min) since last cigarette prior to the session (Table 
4). The two cigarette groups also reported comparable cigarette craving on (total and subscales of) the QSU 
on arrival at the session. 
 
A significant main effect of cigarette smoking status for expired CO levels was found (Table 4), indicating 
that cigarette smokers had significantly greater CO levels compared to non-smokers of cigarettes at arrival 
to the session. No significant main effect of cannabis smoking status or a cannabis x cigarette smoking 
status interaction were revealed.  
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Comparison of trait only participants and behavioural impulsivity sample 
 The behavioural impulsivity sample did not differ significantly from participants who had only completed 
the trait impulsivity measures in terms of age, sex ratio, drug use or trait impulsivity scores (see Table 5). 
 
Reflection impulsivity  
P(correct). For FW trials no significant main effects for cigarette or cannabis smoking status, (both F < 1, 
p ≥ .370, ηp ≤ .01), were revealed on p(correct); there was, however, a significant cannabis x cigarette 
smoking status interaction, (F(1, 83) = 9.14, p = .003, ηp = .10). The three smoking groups had similar 
p(correct) scores that were lower than non-smokers of either substance; see Figure 2a. Simple effects 
analyses showed that cigarette only (p = .001) and cannabis only (p = .011) smokers had significantly lower 
p(correct) scores compared to non-smokers. However, using both cigarettes and cannabis together did not 
lead to significantly further reductions in p(correct) scores relative to using either cigarettes (p = .101) or 
cannabis (p = .202) alone.  
 
For DW trials there were no significant main or interaction effects for p(correct), (all F(1, 83) ≤ 2.58, p ≥ 
.112, ηp = .03; see Figure 2b).   
 
Boxes opened. For FW number of boxes opened, there was no significant main effect of cannabis smoking 
status, (F < 1, p = .541, ηp = .01), but a significant main effect of cigarette smoking status, (F(1, 83) = 4.26, 
p = .042, ηp = .05), and a significant cigarette smoking x cannabis smoking status interaction, (F(1, 83) = 5.52, 
p = .021, ηp = .06). Simple effects analyses revealed cigarette only (p < .001) and cannabis only (p = .043) 
smokers opened significantly fewer boxes compared to non-smokers of either substance. However, using 
both cigarettes and cannabis was not associated with a further reduction in box opening, relative to using 
either cigarettes (p = .213) or cannabis (p = .863) alone, see Figure 3a.  
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For DW number of boxes opened there was a significant main effect of cigarette smoking status, (F(1, 83) = 
4.30, p = .041, ηp = .05), such that smokers of cigarettes opened significantly fewer boxes compared to 
individuals who did not smoke cigarettes (Figure 3b). There was no significant main effect for cannabis 
smoking status or cigarette x cannabis status interaction on the number of boxes opened (both F < 1, p ≥ 
.513, ηp ≤ .01). 
 
Incorrect judgments. For FW incorrect judgments there were no significant main effects for cigarette or 
cannabis smoking status, (both F < 1, p ≥ .726, ηp ≤ .00); however there was a significant cigarette x 
cannabis smoking status interaction, (F(1, 83) = 9.59, p = .003, ηp = .10). Simple effects analyses showed 
cigarette only (p = .003) and cannabis only (p = .021) smokers made significantly more incorrect 
judgements compared to non-smokers of either substance. In this case, cigarette only (p = .046) but not 
cannabis only smokers (p > .999), also made significantly more incorrect judgements relative to users of 
both drugs, see Figure 4a.  
 
For DW incorrect judgements there were no significant main or interaction effects, (all F(1, 83) ≤ 2.74, p ≥ 
.102, ηp ≤ .03; see Figure 4b).   
 
Latency of box opening. A significant main effect of cigarette smoking status on FW latency of box 
opening, (F(1, 83) = 4.53, p = .036, ηp = .05), revealed cigarette smokers took longer to open boxes than non-
cigarette smokers. There was no significant main effect of cannabis status or cigarette x cannabis interaction 
however, (both F < 1, p ≥ .550, ηp ≤ .00; see Figure 5a).  
 
There was also a significant main effect of cigarette smoking for DW latency of box opening, (F(1, 83) = 
4.08, p = .047, ηp = .05), this time qualified by a significant cigarette smoking x cannabis smoking status 
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interaction, (F(1, 83) = 5.47, p = .022, ηp = .06). Simple effects analyses showed cigarette only, (p = .778) 
and cannabis only, (p = .300) smokers did not differ significantly from non-smokers on time spent opening 
boxes. However, cannabis plus cigarette smokers spent significantly longer opening boxes than cigarette 
only, (p = .024) and cannabis only smokers, (p = .010), see Figure 5b. There was no significant main effect 
of cannabis status, (F < 1, p = .408, ηp = .01) 
 
Total points won. For FW total points won there were no significant main effects for cigarette or cannabis 
smoking status, (both F < 1, p ≥ .726, ηp ≤ .00); however, there was a significant cigarette x cannabis 
smoking status interaction, (F(1, 83) = 9.59, p = .003, ηp = .10). Simple effects analyses showed cigarette 
only, (p = .003) and cannabis only, (p = .021) smokers won significantly fewer total points than non-
smokers. Cigarette only (p = .046) but not cannabis only smokers (p > .999), also won significantly fewer 
points than cannabis plus cigarette smokers, see Figure 6a.  
 
In contrast, for DW trials there was no significant main or interaction effects on total points won (all F(1, 83) 
≤ 2.26, p ≥ .136, ηp ≤ .03; see Figure 6b).   
 
Response inhibition  
There were no significant main or interaction effects on SSRT or any secondary dependent variables of the 
SST, (all F(1, 73) ≤ 2.86, p ≥ .095, ηp ≤ .04); see Table 6 for SST dependent variable descriptive statistics.  
 
Discussion  
It is unclear from existing research how the role of impulsivity may differ across cannabis only, cigarette 
only and cigarette plus cannabis users, and to what extent cigarette smoking may account for the heightened 
impulsivity previously found in cannabis users. To explore this, the present study assessed the effects of 
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cigarette and cannabis smoking on trait and behavioural impulsivity across a sample of non-smokers, 
cigarette only, cannabis only, and cigarette plus cannabis smokers. Findings demonstrated clear differences 
between these groups on elements of trait and behavioural impulsivity, and how these relate to key cigarette 
and cannabis use outcomes, suggesting that unique aspects of impulsivity may be differentially related to 
cannabis and cigarette smoking. Each of these findings will be discussed in more detail below.   
 
Total, attention and non-planning trait impulsivity were significantly higher in cigarette smokers (cannabis 
and non-cannabis users) compared to individuals who did not smoke cigarettes. Elevated trait motor 
impulsiveness was also observed in cigarette smokers, however, on this component of impulsivity the effect 
of cigarette smoking was specific to those who did not also use cannabis. In contrast, trait impulsivity 
appeared to be unrelated to cannabis use. The present findings stand in opposition to previous research 
demonstrating greater trait motor and non-planning impulsivity in cannabis only smokers compared to non-
smokers (Gilman et al., 2015), instead suggesting that impulsive tendencies may be especially prevalent in 
cigarette smokers compared to NS. The present findings are however consistent with previous work 
demonstrating elevated trait impulsivity on the BIS-11 in both cigarette only and cannabis plus cigarette 
smokers compared to NS (Dougherty et al., 2013; Mitchell, 1999; Moreno et al., 2012), and also with those 
reporting comparable levels of trait impulsiveness between cigarette only and cannabis plus cigarette 
smokers (Beaton et al., 2014).    
 
Exploratory correlations between self-reported drug use and trait impulsivity in each drug user group 
revealed significant positive relationships between the number of cigarettes smoked per day and total trait 
impulsivity in both the cigarette only and cannabis plus cigarette groups. Number of cigarettes smoked per 
day was also significantly positively associated with greater motor and non-planning impulsiveness in 
cigarette only smokers. In addition, greater nicotine dependence was significantly positively associated 
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with trait total, motor and non-planning impulsiveness in cigarette only smokers, whilst in cannabis plus 
cigarette smokers only attentional impulsiveness was related to level of nicotine dependence. Therefore, 
whilst relationships between trait impulsivity and indicators of nicotine dependence were detected in both 
cigarette smoking groups, these associations differed between cigarette only and cannabis plus cigarette 
groups across subscales of trait impulsivity. These findings suggest that in cannabis plus cigarette smokers, 
greater tendencies towards distractibility and inattention may play a critical role in the transition to nicotine 
dependence. By contrast, in cigarette only smokers, greater tendencies towards rapid and unpremeditated 
behaviour may instead be integral traits that increase vulnerability for transitioning to nicotine dependence. 
In direct opposition, no significant positive associations were found between trait impulsivity and cannabis 
dependence or frequency of cannabis smoking in either cannabis group. Interestingly, motor impulsivity 
was found to be significantly negatively associated with daily frequency of cannabis smoking providing 
further evidence of the limited role heightened trait impulsivity may play in cannabis use relative to 
cigarette smoking.       
 
Taken together, these differences between cigarette and cannabis users in elements of trait impulsivity and 
in how they relate to key outcomes, suggest that a failure to assess and/or control for cigarette smoking may 
be responsible for inconsistencies in past research exploring trait impulsivity in cannabis smokers. Given 
the robust associations shown between variation in mesocorticolimibic dopamine functioning, integrity of 
frontostriatal circuitry and levels of trait impulsivity (e.g. Buckholtz and Meyer-Lindenberg, 2012; Volkow 
et al., 2011), differences in trait impulsivity observed in cigarette smokers compared to non-cigarette 
smokers may indicate that heightened trait impulsiveness increases risk for tobacco cigarette smoking but 
may not be uniquely related to cannabis smoking. Alternatively, it is possible that trait impulsivity is 
influenced by prolonged cigarette smoking suggesting trait propensities are not entirely stable constructs. 
It may be that regular exposure to greater levels of nicotine with or without co-morbid cannabis smoking 
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leads to distinct changes in some dimensions of trait impulsivity as compared to cannabis smoking alone. 
Supporting this argument, pre-clinical studies indicate that chronic nicotine administration increases 
behavioural disinhibition (Kolokotroni et al., 2012) and impulsive choice (Kayir et al., 2014) in rodents. 
Furthermore, longitudinal assessment in other psychostimulants has found increased cocaine intake to be 
associated with elevated trait impulsivity on the BIS-11 while decreased intake was associated with reduced 
impulsivity at follow-up (Hulka et al., 2015). Against this view however, no significant positive correlations 
between trait impulsivity and years smoking tobacco were revealed in the present study, which would be 
expected if heightened trait impulsivity was a consequence of chronic nicotine-induced neural adaptations. 
It is imperative that future longitudinal research is conducted to determine whether trait impulsivity predates 
and/or is affected by extended drug use, to further understand its role in addiction and clarify its potential 
as an intervention target. 
 
No significant effects of cigarette or cannabis smoking status were revealed on response inhibition. The 
present findings extend existing research (Filbey and Yezhuvath, 2013; Grant et al., 2012) demonstrating 
that capacity for response inhibition on the SST is comparable in cannabis smokers compared to non-
cannabis smokers. Whilst impairments in response inhibition on the SST have been reported in cannabis 
smokers previously (Ramaekers et al., 2006), such observations have been limited to performance whilst 
under the acute influence of THC. Cannabis smokers in the present study on average smoked approximately 
13 hours before the session, suggesting that previously reported cannabis-induced impairments in response 
inhibition may be transient. Findings are also consistent with previous work comparing cigarette smokers 
and non-smokers reporting comparable response inhibition on the SST (Beckker et al., 2005), a Stroop task 
(Powell et al., 2002) and an antisaccadic task (Domier et al., 2007), but not with others indicating reduced 
response inhibition in cigarette smokers on the go/no-go task (Luijten et al., 2011). Discrepancies in 
findings may be due to differences between tasks in the aspects of behavioural inhibition they measure and 
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the partially distinct neuropharmacological mechanisms they rely on (Eagle et al., 2008). The SST assesses 
action cancellation (i.e. stopping a pre-potent motoric response after it is initiated) and task performance is 
improved by administration of atomoxetine, a selective norepinephrine reuptake inhibitor (Broos et al., 
2012). In contrast, the go/no-go task assesses action restraint (i.e. inhibiting of a pre-potent motoric 
response before it is initiated) and task performance is impaired following serotonin depletion (Harrison et 
al., 1999). 
 
During FW trials on the IST, impaired reflection impulsivity was demonstrated in individuals who smoked 
cigarettes alone or cannabis alone relative to non-smokers of either substance. Impaired reflection was 
demonstrated in both these drug groups compared to non-smokers, evidenced through lower p(correct) 
reflective of decision-making under high levels of uncertainty, with limited information (opening fewer 
boxes), resulting in more incorrect judgments and fewer total points won. This heightened impulsive 
responding was restricted to FW trials where there were no penalties for sampling information, consistent 
with previous research in other drug users (Clark et al., 2006). However, there was some indication of 
reduced information sampling in DW trials in cigarette smokers (irrespective of cannabis use) compared to 
non-cigarette smokers, suggesting cigarette smoking may increase impulsive decision-making during 
situations involving potential risk.  
 
Importantly, on FW trials, neither p(correct) - which is the main index of reflection impulsivity - nor number 
of boxes opened were altered further in those who smoked cigarettes and cannabis, suggesting co-morbid 
cigarette-cannabis smoking does not have additive effects on reflection impulsivity. On the contrary, those 
who smoked cigarettes alone made more incorrect judgements and won fewer total points than those who 
smoked both cigarettes and cannabis. However, the relevance of these findings is diminished given that the 
accuracy of judgements and total amount of points won do not directly quantify the amount of information 
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sampled prior to decision-making (Clark et al., 2006), making these variables less valid measures of 
reflection impulsivity than p(correct).  
 
Group differences were also observed in latency of box opening on the IST. During FW trials, cigarette 
smoking was associated with slower responses, whilst it was combined cigarette and cannabis smoking that 
was associated with slower responses in the DW condition. Speed of box opening has been argued to offer 
an insight into task-related arousal (Clark et al., 2006), suggesting that these findings may reflect differences 
in motivation towards the task as a function of cannabis and cigarette smoking. Reassuringly however, the 
group differences found in latency of box opening did not reflect those found for p(correct), suggesting any 
motivation differences that may be indicated by the latency findings are unlikely to explain the differences 
in reflection impulsivity that were found. Furthermore, all groups sampled less information during DW 
than FW trials, suggesting they were sensitive to the differing reward contingencies of the task and 
motivated to win points.   
 
These findings are the first to demonstrate that cigarette smoking or cannabis smoking alone significantly 
impair reflection impulsivity relative to no drug use. Data suggest that co-morbid cigarette-cannabis 
smoking does not have additive impairing effects on reflective decision-making. Findings extend previous 
work reporting poor reflection impulsivity in cannabis smokers where the additive effect of these drugs was 
not tested (Clark et al., 2009; Solowij et al., 2012). Less thoughtful decision-making may therefore be one 
mechanism by which cannabis smoking and cigarette smoking are independently maintained, through users 
being prepared to accept greater risks regarding their decisions, such as the negative health and financial 
consequences of their decision to smoke. Importantly, these findings have implications for drug 
rehabilitation. Continuing to smoke either cigarettes or cannabis whilst attempting to quit the other may 
sustain drug-induced impulsive behaviour leading to poorer judgements and increased likelihood of drug 
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relapse during attempted abstinence. Indeed, previous research strongly supports this view, demonstrating 
cigarette smoking during cannabis abstinence significantly increases risk of relapse compared to those who 
do not smoke cigarettes (Haney et al., 2013). Taken together with the present study’s findings suggesting 
that cigarette smoking or cannabis smoking each impair reflective decision making, it is imperative that 
interventions aim to stop use of both drugs in parallel to reduce risk of relapse, in line with previous 
suggestions (Rabin and George, 2015). 
 
In the present study, different findings were observed between distinct dimensions of behavioural 
impulsivity. Differential performance on the IST and SST have been previously reported in other participant 
groups (e.g. Huddy et al., 2013; Jepsen et al., 2018), and is likely to reflect variations in task nature that 
rely on the integrity of partially distinct neurobiological systems (Caswell et al., 2015). Specifically, 
inhibitory control tasks involve withholding motoric responding to pre-potent stimuli, responding is highly 
time-sensitive, and the activity of the right inferior frontal gyrus and anterior insula is integral for inhibitory 
control (Aron et al., 2014; Eagle et al., 2008; Hampshire and Sharp, 2015). In contrast, the IST involves 
decision-making under uncertainty and responding is not time-sensitive. Although the neurobiological 
mechanisms underlying reflection impulsivity are currently not well defined, recent evidence suggests that 
inhibitory control and reflection impulsivity may be mediated by distinct physiological mechanisms 
(Herman et al., 2019). An important further step for future research is to also explore differences between 
non-smokers, cannabis only, cigarette only and cigarette plus cannabis smokers on measures on impulsive 
choice (e.g. delay discounting) given that this form of impulsivity is also behaviourally and 
neurobiologically distinct from the two dimensions studied (de Wit, 2009; Caswell et al., 2015). 
Behavioural impulsivity may also be greater when performance is measured in the context of drug-related 
rewards. Indeed, heightened response disinhibition and impulsive choice has been previously found when 
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drug-related stimuli are presented relative to non-drug stimuli in various drug users (e.g. Pike et al., 2013; 
Weafer and Fillmore, 2012; Zeeb et al., 2010). 
 
Limitations 
Despite clear distinctions in trait and behavioural impulsivity across drug user groups, some limitations of 
the study need to be addressed. Although cannabis groups did not differ in frequency and duration of 
cannabis use, cannabis plus cigarette smokers indicated significantly higher levels of cannabis dependence 
than cannabis only smokers on the CUDIT-R. This distinction was only present in groups being compared 
on trait impulsivity. A possible reason for heavier levels of cannabis dependence in cannabis plus cigarette 
smokers may be related to their co-morbid smoking of cigarettes, consistent with previous work indicating 
cigarette smoking promotes greater levels of cannabis dependence (Hindocha et al., 2015). However, the 
impact of this on data in the present study is likely to have been minimal given: 1) that no significant 
correlations between trait impulsivity and cannabis dependence were found, and 2) heavier cannabis 
dependence reported in the cannabis plus cigarette group would bias results in favour of an additive effect 
of co-morbid cannabis-cigarette smoking on impulsivity, which was not found. Furthermore, previous 
research has indicated that level of dependence may be less accurate at predicting motivation for cannabis 
than weekly use (Cousijin et al., 2011), a measure that was consistent across groups in the current study.  
 
The present findings also need to be considered in view of the fact that cannabis only smokers were not 
truly naïve to nicotine, as the majority of individuals in both cannabis smoking groups acknowledged using 
tobacco in their joints. However, this is highly consistent with European norms of cannabis smoking, where 
the majority of users smoke cannabis joints with tobacco (Hindocha et al., 2016; Hindocha et al., 2015). 
Additionally, cannabis plus cigarette smokers reported using significantly more tobacco in their joints than 
cannabis only smokers, and self-reported smoking status of cannabis only smokers was further confirmed 
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through biochemical (CO) assessment, demonstrating CO levels equivalent to a non-smoker (Cox and 
Whichelow, 1985), thereby providing strong support for the legitimate classification of groups. Importantly, 
impulsivity differences were still observed between cannabis groups, strongly supporting the idea that 
despite both groups being exposed to nicotine via their joints, these individuals likely face different 
challenges relating to their drug use, which may in turn have implications for distinct treatment needs. 
 
Although groups did not differ in time of last cigarette or cannabis use prior to the session and current 
smoking status of individuals was supported by CO data, the amount of each drug used before the session 
was not restricted. Although consistent with protocols of previous investigations in these drug users (e.g. 
Lawn et al., 2017; Smith et al., 2007), stricter control of quantity of drug use prior to the session is an 
important consideration for future research. The level of alcohol use was also not controlled for in the 
present study. Whilst participants were excluded if they reported alcohol dependency, levels of recreational 
alcohol may have differed across groups and could have potentially impacted upon levels of impulsive 
behaviour (e.g. Reed et al, 2012).  
 
Conclusions 
Previous research attempting to understand factors underlying problematic cannabis use may have been 
limited by many studies overlooking the effects of co-morbid cigarette smoking. The present study was the 
first step towards disentangling the effects of these substances by exploring the effects of both cannabis and 
cigarette smoking on dimensions of trait and behavioural impulsivity in a sample of non-smokers, cigarette 
only, cannabis only and cannabis plus cigarette smokers. The main findings of this study demonstrate that 
significantly higher trait impulsivity was found in cigarette smokers, with elevated motor impulsiveness 
being confined to those who did not also use cannabis. Elevated trait impulsiveness in cigarette only and 
cannabis plus cigarette groups may be a risk factor for the initiation of cigarette smoking and greater levels 
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of nicotine dependence. In contrast, trait impulsivity does not appear to be related to increased cannabis 
smoking or dependence. Cigarette smoking or cannabis smoking appear to independently significantly 
impair capacity to reflect on information prior to decision-making, but interestingly, when used co-
morbidly do not have an additive effect on the degree of uncertainty tolerated at the point of decision-
making. In support of recent recommendations, that tobacco use should be controlled in research on health 
outcomes in cannabis use (Lovell et al., 2018), the present findings highlight the importance of cigarette 
smoking within the context of understanding the relationship between cannabis smoking and impulsivity. 
Treatment of cannabis dependence may benefit from tailoring interventions depending on whether 
individuals are co-morbid cigarette smokers; programmes targeting those who smoke both substances may 
benefit from ceasing use of both drugs in parallel to reduce risk of impaired reflection thereby increasing 
likelihood of abstinence.      
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Table legends: 
Table 1. Trait impulsivity participant sample demographics and smoking behaviour (N=224). Data 
 presented as mean (SD) or frequency. NS = non-smoker of cigarettes and cannabis, CAN NON-CIG =
 cannabis only smoker, CIG = cigarette only smoker, CAN CIG = cannabis plus cigarette smoker, M =
 male, F = female, FTND = Fagerström test for nicotine dependence, CUDIT-R = Cannabis use disorders
 identification test - revised. F values presented refer to 2 (cannabis status) x 2 (cigarette status) ANOVA
 statistics. Asterisks indicate level of significance
 
* p <.05 ** p < .01.  
 
Table 2. Pearson’s correlations between trait impulsivity and tobacco use and dependence by group. Data 
 represent Pearson’s r correlation coefficients. CIG = cigarette only, CAN CIG = cannabis plus cigarette
 smoker. Asterisks indicate level of significance
 
* p <.05 ** p < .01. 
 
Table 3. Pearson’s correlations between trait impulsivity and cannabis use and dependence by group. Data
 represent Pearson’s r correlation coefficients. CAN NON-CIG = cannabis only smoker, CAN CIG = 
 cannabis plus cigarette smoker. Asterisks indicate level of significance
 
* p <.05 ** p < .01. 
 
Table 4. Behavioural impulsivity participant sample demographics and smoking behaviour (N=87). Data presented 
as mean (SD) or frequency. NS = non-smoker of cigarettes and cannabis, CAN NON-CIG = cannabis only 
smoker, CIG = cigarette only smoker, CAN CIG = cannabis plus cigarette smoker, M = male, F = female, 
FTND = Fagerström test for nicotine dependence, CUDIT-R = Cannabis use disorders identification test – 
revised, CO = carbon monoxide. F values presented refer to 2 (cannabis status) x 2 (cigarette status) 
ANOVA statistics. Asterisks indicate level of significance
 
*** p < .001.  
 
Table 5. Comparison of trait-only participants and behavioural sample on demographics, drug use, and trait 
impulsivity. Data presented as mean (SD) or frequency. M = male, F = female, FTND = Fagerström test for 
nicotine dependence, CUDIT-R = Cannabis use disorders identification test - revised.    
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Table 6. Descriptive statistics for stop-signal task group comparisons. Data presented as mean (SD). NS = non-
 smoker of cigarettes and cannabis, CAN NON-CIG = cannabis only smoker, CIG = cigarette only smoker,
 CAN CIG = cannabis plus cigarette smoker SSRT = Stop-signal RT, SSD = Stop-signal delay, 
 P(respond|signal) = probability of responding on stop-signal trials, ms = milliseconds.  
 a Ten participants (six non-smokers, two cigarette only, one cannabis only, one cannabis plus cigarette
  smokers) were excluded from SST analysis due to inability to accurately estimate SSRT.  
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Table 1. 
  NS CAN NON-CIG CIG CAN CIG Test statistic   P value Effect size 
N 44  47  76  58  - - - 
Age years **   24.73 (4.57) 21.98 (4.59) 23.55 (5.75) 22.62 (3.37) Cannabis main effect F(1, 221)=8.05  
Cigarette main effect F(1, 221)<1 
Cannabis*cigarette interaction F(1, 221)=1.96 
.005 
.682 
.163 
ηp2=.04 
ηp2=.00 
ηp2=.01 
Sex M:F 25:19 - 30:17 - 42:34 - 43:15 - Χ2(3)=5.67 .130 - 
Cigarettes smoked per day - - - - 10.66 (4.93) 9.46 (5.12) t(128)=1.35 .179 d=.24 
Years smoking tobacco - - - - 5.89 (5.68) 5.30 (3.54) t(127)<1 .494 d=.13 
FTND  - - - - 3.19 (2.23) 2.89 (2.09) t(128)<1 .440 d=.14 
Proportion of time using tobacco in joints (%) - - 73.41 (32.67) - - 90.25*  (12.50) U=1026.50 .030 r=.21 
Days per week smoking cannabis - - 5.11 (1.87) - - 5.51 (1.78) t(101)=1.11 .270 d=.22 
Days per month smoking cannabis - - 21.09 (8.03) - - 23.44 (7.28) t(101)=1.56 .123 d=.31 
Years smoking cannabis - - 4.62 (3.75) - - 5.71 (4.08) t(101)=1.40 .164 d=.28 
CUDIT-R - - 16.72 (3.91) - - 18.81* (4.58) t(101)=2.45 .016 d=.49 
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Table 2. 
 
BIS-11 
CIG Total Attention Motor Non-plan 
Cigarettes smoked per day (n=73) .27* .05 .26* .32** 
Years smoking tobacco (n=72) -.23* -.19 -.16 -.22 
FTND (n=73) .33** .19 .27* .34** 
CAN CIG     
Cigarettes smoked per day (n=56) .28* .21 .25 .21 
Years smoking tobacco (n=57) .17 .09 .13 .19 
FTND (n=57) .17 .28* .10 .07 
 
 
Table 3. 
 
BIS-11 
CAN NON-CIG Total Attention Motor Non-plan 
Days per week smoking cannabis (n=46) -.18 -.11 -.03 -.28 
Years smoking cannabis (n=46) .04 -.08 .10 .06 
CUDIT-R (n=46) .04 .26 -.03 -.08 
CAN CIG     
Days per week smoking cannabis (n=57) -.17 .00 -.30* -.09 
Years smoking cannabis (n=57) .15 .11 .09 .17 
CUDIT-R (n=57) .15 .05 .09 .21 
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Table 4. 
  NS CAN NON-CIG CIG CAN CIG Test statistic   P value Effect size 
N 30  13  29  15  - - - 
Age years  24.43 (4.15) 22.23 (2.83) 24.97 (7.21) 24 (4.36) Cannabis main effect F(1, 83)=1.70  
Cigarette main effect F(1, 83)<1 
Cannabis*cigarette interaction F(1, 83)<1 
.196 
.346 
.612 
ηp2=.02 
ηp2=.01 
ηp2=.00 
Sex M:F 14:16 
 
6:07  15:14 
 
12:03  Χ2(3)=5.12 .172 - 
Cigarettes smoked per day - 
 
- 
 
- - 9.88 
 
(4.83) 
 
11.83 (6.01) t(42)=1.17 .249 d=.36 
Years smoking tobacco - 
 
- 
 
- - 6.52 
 
(6.13) 
 
6.03 (4.72) t(42)<1 .791 d=.09 
FTND  - 
 
- 
 
- - 3.10 
 
(2.35) 
 
3.53 (1.64) t(42)<1 .531 d=.22 
Proportion of time using tobacco in joints (%) - 
 
- 
 
84.17 (18.89) - 
 
- 
 
87.80 (9.54) U=96.50 .972 r=.01 
Days per week smoking cannabis - 
 
- 
 
5.00 (1.91) - 
 
- 
 
5.40 (1.97) t(26)<1 .591 d=.21 
Days per month smoking cannabis - 
 
- 
 
21.42 (8.01) - 
 
- 
 
23.30 (8.21) t(26)<1 .547 d=.23 
Years smoking cannabis - 
 
- 
 
4.46 (2.50) - 
 
- 
 
7.01 (5.53) t(20.06)=1.61 .124 d=.64 
CUDIT-R - 
 
- 
 
16.38 (4.33) - 
 
- 
 
17.33 (3.48) t(26)<1 .526 d=.24 
CO (parts per million) *** 2.10 
 
(0.88) 
 
3.42 
 
(1.24) 
 
10.34 (7.71) 
 
11.80 (4.31) 
 
Cannabis main effect F(1, 130)=3.76 
Cigarette main effect F(1, 130)=50.83 
Cannabis*cigarette interaction F(1, 130)<1 
.055 
<.001 
.466 
ηp2=.03 
ηp2=.28 
ηp2=.00 
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Time (min) of last cigarette before session - - - - 30.00 (57.50) 20.00 (47.50) U=214.50 .946 r=.01 
Time (hours) of last cannabis use before session - - 14:00 (4.25) - - 12:00 (4.50) U=56.00 .055 r=.36 
QSU total craving - - - - 41.38 (27.97) 32.60 (21.03) t(42)=1.07 .292 d=.36 
QSU positive craving - - - - 26.07 (15.11) 23.00 (14.03) t(42)=1.42 .165 d=.21 
QSU negative craving - - - - 15.31 (14.37) 9.60 (8.38) t(42)<1 .517 d=.50 
MCQ total craving - - 43.69 (11.22) - - 45.29 (8.96) t(25)<1 .686 d=.16 
Compulsivity craving - - 6.08 (3.52) - - 6.80 (2.81) t(26)<1 .551 d=.23 
Emotionality craving - - 10.08 (3.17) - - 10.07 (3.85) t(26)<1 .994 d=.00 
Expectancy craving - - 13.62 (3.91) - - 13.47 (3.29) t(26)<1 .914 d=.04 
Purposefulness craving - - 13.92 (4.17) - - 15.27 (4.04) t(26)<1 .395 d=.33 
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Table 5. 
 Trait-only 
participants   
Behavioural 
sample  
Test 
statistic   
P value Effect 
size 
N 137  87  - - - 
Age 23.50 (5.05) 24.21 (5.27) t(222)<1 .319 d=.14 
Sex M:F 81:56 - 47:40 - Χ2(1)<1 .490 - 
Cigarettes smoked per day 9.93 (5.07) 10.55 (5.28) t(102)<1 .546 d=.12 
Years smoking tobacco 6.13 (5.09) 6.35 (5.63) t(102)<1 .830 d=.04 
FTND 3.20 (2.16) 3.25 (2.13) t(102)<1 .907 d=.02 
Proportion of time using tobacco in 
joints (%) 
80.32 (27.51) 85.82 (14.21) U=1068.50 .944 r=.01 
Days per week smoking cannabis 5.12 (1.90) 5.21 (1.92) t(103)<1 .817 d=.05 
Days per month smoking cannabis 21.49 (8.16) 22.43 (8.02) t(103)<1 .603 d=.12 
Years smoking cannabis 5.39 (4.15) 5.83 (4.51) t(103)<1 .638 d=.10 
CUDIT-R 17.12 (4.19) 16.89 (3.85) t(103)<1 .805 d=.06 
BIS-11 total 66.60 (10.84) 66.63 (10.70) t(222)<1 .982 d=.00 
Attention 17.47 (4.08) 17.30 (4.12) t(222)<1 .765 d=.04 
Motor 24.36 (4.62) 24.39 (4.51) t(222)<1 .967 d=.01 
Non-Plan 24.77 (4.80) 24.94 (4.82) t(222)<1 .790 d=.04 
 
 
Table 6. 
  NS   CAN NON-
CIG 
  CIG   CAN 
CIG 
  
Na  24  12  27  14  
SSRT (ms) 277.7
0 
(32.07) 282.43 (32.28) 260.9
1 
(63.60) 289.52 (71.51) 
SSD (ms) 275.4
2 
(114.0
1) 
325.78 (189.8
6) 
390.6
6 
(187.7
7) 
309.32 (147.4
2) 
P(respond|signal) (%) 48.23 (4.71) 47.43 (4.93) 47.35 (5.84) 48.05 (6.45) 
Correct responses (%) 98.39 (1.94) 97.00 (3.88) 96.90 (5.02) 97.59 (2.04) 
Missed responses (%) 0.94 (1.87) 2.12 (3.92) 1.46 (2.16) 1.36 (2.30) 
Commission error RT 
(ms) 
477.2
9 
(89.38) 522.53 (141.0
6) 
569.8
5 
(133.5
0) 
523.80 (112.5
8) 
Correct response RT 
(ms) 
553.7
9 
(111.7
5) 
609.37 (174.1
9) 
651.8
8 
(154.2
9) 
599.86 (157.3
0) 
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Figure legends: 
Figure 1. Main effect of cigarette status for BIS-11 total (a), attention (b) and non-planning subscales (c). Cigarette 
 x cannabis status interaction for BIS-11 motor impulsivity score (d). Bars represent mean ± SEM. Asterisks
 indicate level of significance *** p < .001.  
 
Figure 2. P(correct) for (a) FW cigarette x cannabis status interaction and (b) DW descriptive statistics. Bars 
 represent mean ±SEM. Asterisks indicate level of significance * p < .05 *** p < .001.  
 
Figure 3. Number of boxes opened for (a) FW cigarette x cannabis status interaction and (b) DW main effect of
 cigarette status. Bars represent mean ± SEM. Asterisks indicate level of significance * p < .05 *** p <
  .001. 
 
Figure 4. Incorrect judgements for (a) FW cigarette x cannabis status interaction and (b) DW descriptive statistics.
 Bars represent mean ±SEM. Asterisks indicate level of significance * p < .05 ** p < .01.  
 
Figure 5. Latency of box opening for (a) FW main effect of cigarette status and (b) DW cigarette x cannabis status
 interaction. Bars represent mean ± SEM. Asterisks indicate level of significance * p < .05. 
 
Figure 6. Total points won for (a) FW cigarette x cannabis status interaction and (b) DW descriptive statistics. Bars
 represent mean ±SEM. Asterisks indicate level of significance * p < .05 ** p < .01.    
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